Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China · Delayed Price · Currency is CNY 98.80
-2.70 (-2.66%)
Apr 17, 2026, 3:00 PM CST
SHA:688266 Revenue
In the year 2025, Suzhou Zelgen Biopharmaceuticals had annual revenue of 810.48M CNY with 52.07% growth. Suzhou Zelgen Biopharmaceuticals had revenue of 217.04M in the quarter ending December 31, 2025, with 45.83% growth.
Revenue
810.48M
Revenue Growth
+52.07%
P/S Ratio
32.27
Revenue / Employee
890.64K
Employees
910
Market Cap
26.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 810.48M | 277.53M | 52.07% |
| Dec 31, 2024 | 532.95M | 146.52M | 37.91% |
| Dec 31, 2023 | 386.44M | 84.13M | 27.83% |
| Dec 31, 2022 | 302.31M | 111.94M | 58.81% |
| Dec 31, 2021 | 190.36M | 162.70M | 588.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition